Literature DB >> 14690858

Herpes simplex virus infection and apoptosis.

Margot L Goodkin1, Elise R Morton, John A Blaho.   

Abstract

Consequences of human herpes simplex virus (HSV) infection include the induction of apoptosis and the concomitant synthesis of proteins which act to block this process from killing the infected cell. Recent data has clarified our current understanding of the mechanisms of induction and prevention of apoptosis by HSV. These findings emphasize the fact that modulation of apoptosis by HSV during infection is a multicomponent phenomenon. We review recent evidence showing how this important human pathogen modulates the fundamental cell death process.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14690858     DOI: 10.1080/08830180490265574

Source DB:  PubMed          Journal:  Int Rev Immunol        ISSN: 0883-0185            Impact factor:   5.311


  21 in total

1.  Influenza virus infection increases p53 activity: role of p53 in cell death and viral replication.

Authors:  Elizabeth Turpin; Kimberly Luke; Jeremy Jones; Terrence Tumpey; Kouacou Konan; Stacey Schultz-Cherry
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

2.  Herpes Simplex Virus 1 Infection of Tree Shrews Differs from That of Mice in the Severity of Acute Infection and Viral Transcription in the Peripheral Nervous System.

Authors:  Lihong Li; Zhuoran Li; Erlin Wang; Rui Yang; Yu Xiao; Hongbo Han; Fengchao Lang; Xin Li; Yujie Xia; Feng Gao; Qihan Li; Nigel W Fraser; Jumin Zhou
Journal:  J Virol       Date:  2015-10-28       Impact factor: 5.103

3.  Apoptosis and antigen receptor function in T and B cells following exposure to herpes simplex virus.

Authors:  Jin-Young Han; Derek D Sloan; Martine Aubert; Sara A Miller; Chung H Dang; Keith R Jerome
Journal:  Virology       Date:  2006-10-24       Impact factor: 3.616

4.  Herpes simplex virus type 1-induced FasL expression in human monocytic cells and its implications for cell death, viral replication, and immune evasion.

Authors:  Alexandre Iannello; Olfa Debbeche; Raoudha El Arabi; Suzanne Samarani; David Hamel; Flore Rozenberg; Nikolaus Heveker; Ali Ahmad
Journal:  Viral Immunol       Date:  2011-02       Impact factor: 2.257

5.  The ribonucleotide reductase R1 subunits of herpes simplex virus 1 and 2 protect cells against poly(I · C)-induced apoptosis.

Authors:  Florent Dufour; Luc Bertrand; Angela Pearson; Nathalie Grandvaux; Yves Langelier
Journal:  J Virol       Date:  2011-06-22       Impact factor: 5.103

6.  Identification of TRIM23 as a cofactor involved in the regulation of NF-kappaB by human cytomegalovirus.

Authors:  Emma Poole; Ian Groves; Andrew MacDonald; Yin Pang; Antonio Alcami; John Sinclair
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

7.  The antiapoptotic herpes simplex virus glycoprotein J localizes to multiple cellular organelles and induces reactive oxygen species formation.

Authors:  Martine Aubert; Zheng Chen; Robin Lang; Chung H Dang; Carla Fowler; Derek D Sloan; Keith R Jerome
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

8.  Herpes simplex virus blocks apoptosis by precluding mitochondrial cytochrome c release independent of caspase activation in infected human epithelial cells.

Authors:  Martine Aubert; Lisa E Pomeranz; John A Blaho
Journal:  Apoptosis       Date:  2007-01       Impact factor: 4.677

9.  Identification of replication-competent HSV-1 Cgal+ strain signaling targets in human hepatoma cells by functional organelle proteomics.

Authors:  Enrique Santamaría; María I Mora; Corinne Potel; Joaquín Fernández-Irigoyen; Elvira Carro-Roldán; Rubén Hernández-Alcoceba; Jesús Prieto; Alberto L Epstein; Fernando J Corrales
Journal:  Mol Cell Proteomics       Date:  2008-12-19       Impact factor: 5.911

10.  A limited innate immune response is induced by a replication-defective herpes simplex virus vector following delivery to the murine central nervous system.

Authors:  Zane Zeier; J Santiago Aguilar; Cecilia M Lopez; G B Devi-Rao; Zachary L Watson; Henry V Baker; Edward K Wagner; David C Bloom
Journal:  J Neurovirol       Date:  2009-09       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.